TuisSHTDY • OTCMKTS
add
Sinopharm Group ADR
Vorige sluiting
$10,84
Dagwisseling
$11,10 - $11,45
Jaarwisseling
$10,13 - $16,31
Markkapitalisasie
54,36 mjd HKD
Gemiddelde volume
27,00 k
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Des. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 144,89 mjd | -3,82% |
Bedryfskoste | 6,44 mjd | 15,96% |
Netto inkomste | 1,67 mjd | -43,43% |
Netto winsgrens | 1,15 | -41,33% |
Wins per aandeel | — | — |
EBITDA | 5,32 mjd | -35,75% |
Effektiewe belastingkoers | 29,36% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Des. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 54,31 mjd | -19,10% |
Totale bates | 392,83 mjd | 2,46% |
Totale aanspreeklikheid | 266,14 mjd | 1,17% |
Totale ekwiteit | 126,69 mjd | — |
Uitstaande aandele | 3,12 mjd | — |
Prys om te bespreek | 0,43 | — |
Opbrengs op bates | 3,00% | — |
Opbrengs op kapitaal | 5,81% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Des. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,67 mjd | -43,43% |
Kontant van bedrywe | 26,27 mjd | 43,57% |
Kontant van beleggings | -1,36 mjd | 69,47% |
Kontant van finansiering | -19,42 mjd | -266,23% |
Netto kontantverandering | 5,49 mjd | -78,50% |
Beskikbare kontantvloei | 3,14 mjd | -92,00% |
Meer oor
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Gestig
2003
Webwerf
Werknemers
108 217
